{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:07:30Z","timestamp":1784293650891,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2018-12366631"],"award-info":[{"award-number":["RF-2018-12366631"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["IA 52242"],"award-info":[{"award-number":["IA 52242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro Airc","doi-asserted-by":"publisher","award":["IG 2017-ID 19919"],"award-info":[{"award-number":["IG 2017-ID 19919"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R21CA249378-01"],"award-info":[{"award-number":["1R21CA249378-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008091","name":"University of Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.celrep.2023.113120","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:44:22Z","timestamp":1694511862000},"page":"113120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy"],"prefix":"10.1016","volume":"42","author":[{"given":"Valeria","family":"Runfola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giambruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Caronni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pannese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapaola","family":"Andolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-4121","authenticated-orcid":false,"given":"Davide","family":"Gabellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.113120_bib1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.113120_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.23949","article-title":"Risk of functional impairment infacioscapulohumeral muscular dystrophy","volume":"49","author":"Statland","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.celrep.2023.113120_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mus.880181315","article-title":"Facioscapulohumeral muscular dystrophy in the dutch population","volume":"18","author":"Padberg","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.celrep.2023.113120_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JND-150077","article-title":"Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies","volume":"2","author":"Statland","year":"2015","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.celrep.2023.113120_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.nmd.2021.09.010","article-title":"Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings","volume":"31","author":"Jia","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.celrep.2023.113120_bib6","doi-asserted-by":"crossref","first-page":"e2273","DOI":"10.1212\/WNL.0000000000007456","article-title":"FSHD1 and FSHD2 form a disease continuum","volume":"92","author":"Sacconi","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.113120_bib7","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.113120_bib8","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3390\/cells10123322","article-title":"DUX4 role in normal physiology and in FSHD muscular dystrophy","volume":"10","author":"Mocciaro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2023.113120_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ng.3844","article-title":"Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons","volume":"49","author":"Hendrickson","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ng.3846","article-title":"Conservation and innovation in the DUX4-family gene network","volume":"49","author":"Whiddon","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ng.3858","article-title":"DUX-family transcription factors regulate zygotic genome activation in placental mammals","volume":"49","author":"De Iaco","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.22275","article-title":"DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in\u00a0vivo","volume":"69","author":"Wallace","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.celrep.2023.113120_bib14","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","article-title":"DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle","volume":"23","author":"Yao","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib15","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","article-title":"Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways","volume":"24","author":"Rickard","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","article-title":"The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein","volume":"17","author":"Kowaljow","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.celrep.2023.113120_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnen\/60.3.302","article-title":"Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment?","volume":"60","author":"Sandri","year":"2001","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib18","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1093\/hmg\/ddt314","article-title":"Wnt\/\u03b2-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells","volume":"22","author":"Block","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.48.1.46","article-title":"A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group","volume":"48","author":"Tawil","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.113120_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2014.09.014","article-title":"Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial","volume":"81","author":"Passerieux","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","article-title":"Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy","volume":"57","author":"Kissel","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.113120_bib22","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1212\/01.wnl.0000264017.08217.39","article-title":"Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy","volume":"68","author":"Elsheikh","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.113120_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib24","first-page":"661","article-title":"A clinical trial of creatine monohydrate in muscular dystrophy patients","volume":"44","author":"Matsumura","year":"2004","journal-title":"Clin. Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib25","first-page":"931","article-title":"Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy","volume":"254","author":"van der Kooi","year":"2007","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.apmr.2008.12.027","article-title":"Periodic Salbutamol in Facioscapulohumeral Muscular Dystrophy: A Randomized Controlled Trial","volume":"90","author":"Payan","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.celrep.2023.113120_bib27","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1111\/bcp.14884","article-title":"Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement","volume":"87","author":"Mellion","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.celrep.2023.113120_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fneur.2019.00755","article-title":"Preliminary evidences of safety and efficacy of flavonoids- And omega 3-based compound for muscular dystrophies treatment: A randomized double-blind placebo controlled pilot clinical trial","volume":"10","author":"Sitzia","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mus.26113","article-title":"Locally acting ACE-083 increases muscle volume in healthy volunteers","volume":"57","author":"Glasser","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.celrep.2023.113120_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/acn3.158","article-title":"Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation","volume":"2","author":"Homma","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib31","doi-asserted-by":"crossref","first-page":"e13695","DOI":"10.15252\/emmm.202013695","article-title":"Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7","volume":"13","author":"Banerji","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/ijms21030729","article-title":"Dux4 signalling in the pathogenesis of facioscapulohumeral muscular dystrophy","volume":"21","author":"Lim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2023.113120_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13023-021-01760-1","article-title":"Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update","volume":"16","author":"Sch\u00e4tzl","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.celrep.2023.113120_bib34","first-page":"4419","article-title":"Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells","volume":"25","author":"Jagannathan","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib35","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/emboj.2008.201","article-title":"An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies","volume":"27","author":"Bosnakovski","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2023.113120_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2016.08.007","article-title":"DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients","volume":"99","author":"Dmitriev","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1582-4934.2008.00368.x","article-title":"Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects","volume":"14","author":"Barro","year":"2010","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib38","doi-asserted-by":"crossref","first-page":"e26820","DOI":"10.1371\/journal.pone.0026820","article-title":"The FSHD atrophic myotube phenotype is caused by DUX4 expression","volume":"6","author":"Vanderplanck","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.113120_bib39","doi-asserted-by":"crossref","first-page":"e1006658","DOI":"10.1371\/journal.pgen.1006658","article-title":"DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy","volume":"13","author":"Shadle","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2014.02.105","article-title":"Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression","volume":"446","author":"Xu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2023.113120_bib41","doi-asserted-by":"crossref","first-page":"e04996","DOI":"10.7554\/eLife.04996","article-title":"A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy","volume":"4","author":"Feng","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.113120_bib42","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/hmg\/ddz242","article-title":"DUX4-induced bidirectional HSATII satellite repeat transcripts form intranuclear double-stranded RNA foci in human cell models of FSHD","volume":"28","author":"Shadle","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib43","doi-asserted-by":"crossref","first-page":"e143948","DOI":"10.1172\/jci.insight.143948","article-title":"Matrin 3 in neuromuscular disease: physiology and pathophysiology","volume":"6","author":"Malik","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2023.113120_bib44","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1093\/nar\/gkw141","article-title":"DUX4 recruits p300\/CBP through its C-terminus and induces global H3K27 acetylation changes","volume":"44","author":"Choi","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2023.113120_bib45","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/13732","article-title":"A generic protein purification method for protein complex characterization and proteome exploration","volume":"17","author":"Rigaut","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2023.113120_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nmeth1093","article-title":"Mass spectrometry\u2013based functional proteomics: from molecular machines to protein networks","volume":"4","author":"K\u00f6cher","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.113120_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/msb.2008.75","article-title":"An integrated workflow for charting the human interaction proteome: insights into the PP2A system","volume":"5","author":"Glatter","year":"2009","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.celrep.2023.113120_bib48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nmeth.2400","article-title":"Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS","volume":"10","author":"Varjosalo","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.113120_bib49","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1016\/S0021-9258(18)92902-9","article-title":"Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain","volume":"266","author":"Belgrader","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.113120_bib50","doi-asserted-by":"crossref","first-page":"794646","DOI":"10.3389\/fmolb.2021.794646","article-title":"Matrin3: Disorder and ALS Pathogenesis","volume":"8","author":"Salem","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.celrep.2023.113120_bib51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","article-title":"DUX4 expression in FSHD muscle cells: How could such a rare protein cause a myopathy?","volume":"17","author":"Tassin","year":"2013","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib52","doi-asserted-by":"crossref","first-page":"e1001181","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: Incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymeth.2008.06.014","article-title":"Characterizing proteins and their interactions in cells and tissues using the in\u00a0situ proximity ligation assay","volume":"45","author":"S\u00f6derberg","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.celrep.2023.113120_bib54","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1093\/nar\/gkad230","article-title":"WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy","volume":"51","author":"Mocciaro","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2023.113120_bib55","doi-asserted-by":"crossref","first-page":"e75614","DOI":"10.1371\/journal.pone.0075614","article-title":"Multiple Protein Domains Contribute to Nuclear Import and Cell Toxicity of DUX4, a Candidate Pathogenic Protein for Facioscapulohumeral Muscular Dystrophy","volume":"8","author":"Corona","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.113120_bib56","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1093\/hmg\/dds284","article-title":"Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis","volume":"21","author":"Jones","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib57","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.5966\/sctm.2015-0224","article-title":"A human pluripotent stem cell model of facioscapulohumeral muscular dystrophy-affected skeletal muscles","volume":"5","author":"Caron","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molmed.2020.09.008","article-title":"Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy","volume":"27","author":"Cohen","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib59","doi-asserted-by":"crossref","first-page":"e31023","DOI":"10.7554\/eLife.31023","article-title":"NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins","volume":"7","author":"Campbell","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.113120_bib60","doi-asserted-by":"crossref","first-page":"e35977","DOI":"10.7554\/eLife.35977","article-title":"Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization","volume":"7","author":"Malik","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.113120_bib61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40478-020-01021-5","article-title":"RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM","volume":"8","author":"Ramesh","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2023.113120_bib62","doi-asserted-by":"crossref","first-page":"103900","DOI":"10.1016\/j.isci.2022.103900","article-title":"Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology","volume":"25","author":"Sprunger","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2023.113120_bib63","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ana.22149","article-title":"Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis","volume":"69","author":"Douville","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2023.113120_bib65","doi-asserted-by":"crossref","first-page":"307ra153","DOI":"10.1126\/scitranslmed.aac8201","article-title":"Human endogenous retrovirus-K contributes to motor neuron disease","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib66","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.0000000000003258","article-title":"HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy","volume":"87","author":"Bowen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.113120_bib67","doi-asserted-by":"crossref","first-page":"e1006635","DOI":"10.1371\/journal.pgen.1006635","article-title":"Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS","volume":"13","author":"Krug","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.113120_bib69","doi-asserted-by":"crossref","first-page":"e1003947","DOI":"10.1371\/journal.pgen.1003947","article-title":"DUX4 Binding to Retroelements Creates Promoters That Are Active in FSHD Muscle and Testis","volume":"9","author":"Young","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib70","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0960-8966(02)00284-5","article-title":"Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress","volume":"13","author":"Winokur","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.celrep.2023.113120_bib71","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.freeradbiomed.2012.06.041","article-title":"Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction","volume":"53","author":"Turki","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.celrep.2023.113120_bib72","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.celrep.2014.07.056","article-title":"Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 Transgene","volume":"8","author":"Dandapat","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.113120_bib73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajhg.2009.03.006","article-title":"Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3","volume":"84","author":"Senderek","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib74","doi-asserted-by":"crossref","first-page":"14529","DOI":"10.1038\/s41598-017-14924-6","article-title":"ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export","volume":"7","author":"Boehringer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2023.113120_bib75","series-title":"TheOnline Metabolic and Molecular Bases of Inherited Disease","article-title":"Facioscapulohumeral Dystrophy","author":"Neguembor","year":"2015"},{"key":"10.1016\/j.celrep.2023.113120_bib76","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-016-0667-0","article-title":"Facioscapulohumeral Dystrophy","volume":"16","author":"Wang","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.celrep.2023.113120_bib77","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cge.13446","article-title":"Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1","volume":"94","author":"Mul","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.celrep.2023.113120_bib78","doi-asserted-by":"crossref","first-page":"e23882","DOI":"10.1371\/journal.pone.0023882","article-title":"Matrin 3 binds and stabilizes mRNA","volume":"6","author":"Salton","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.113120_bib79","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1074\/jbc.M707479200","article-title":"Genome-wide impact of the BRG1 SWI\/SNF chromatin remodeler on the transforming growth factor beta transcriptional program","volume":"283","author":"Xi","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.113120_bib80","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.molcel.2011.11.005","article-title":"Chemical genetic screen for AMPK\u03b12 substrates uncovers a network of proteins involved in mitosis","volume":"44","author":"Banko","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2023.113120_bib81","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cell.2008.01.019","article-title":"Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly","volume":"132","author":"Venteicher","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.113120_bib82","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.celrep.2023.113120_bib83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2023.113120_bib84","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2023.113120_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10858-009-9371-6","article-title":"Overcoming the solubility limit with solubility-enhancement tags: successful applications in biomolecular NMR studies","volume":"46","author":"Zhou","year":"2010","journal-title":"J.\u00a0Biomol. NMR"},{"key":"10.1016\/j.celrep.2023.113120_bib86","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1021\/pr4003323","article-title":"Affinity purification strategies for proteomic analysis of transcription factor complexes","volume":"12","author":"Giambruno","year":"2013","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.celrep.2023.113120_bib87","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.113120_bib88","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/pr4009892","article-title":"abFASP-MS: affinity-based filter-aided sample preparation mass spectrometry for quantitative analysis of chemically labeled protein complexes","volume":"13","author":"Huber","year":"2014","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.celrep.2023.113120_bib89","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2023.113120_bib90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J.\u00a0Roy. Stat. Soc. B"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723011324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723011324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:32:05Z","timestamp":1769038325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723011324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2211124723011324"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.113120","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.113120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"113120"}}